#VisualAbstract: Definitive chemoradiotherapy and surgical treatment are equally effective primary interventions for patients with advanced oroparyngeal squamous cell carcinoma

byTeddy Guo

June 17, 2021

in StudyGraphics

Reading Time: 1 min read

Wellness Check: Nutrition

RelatedReports

StudyGraphics

#VisualAbstract: Intensity-modulated radiotherapy alone is noninferior to concurrent chemoradiotherapy for low-risk nasopharyngeal carcinoma

October 25, 2022

StudyGraphics

#VisualAbstract: Pembrolizumab provides survival benefit in PD-L1 positive advanced head and neck cancer

October 19, 2022

StudyGraphics

#VisualAbstract: Chemoradiotherapy with carboplatin is more effective than cetuximab in head and neck squamous cell carcinoma

October 18, 2022

#VisualAbstract: Adjuvant ibandronate does not improve survival in postmenopausal patients with ER⁺ breast cancer

StudyGraphics

#VisualAbstract: Tislelizumab significantly improves survival outcomes in advanced or metastatic esophageal squamous cell carcinoma

October 5, 2022

#VisualAbstract Changes in minimal residual disease status is associated with risk of disease progression in patients with multiple myeloma

California’s cystic fibrosis newborn screening model is highly effective

Chemotherapy during the first trimester of pregnancy associated with increased risk for congenital malformations in fetus

Interventional neuroradiology procedures may deliver lens radiation doses exceeding safe thresholds

Direct to angiography in transferred patients with large vessel occlusion stroke associated with faster treatment and better outcomes vs repeat imaging approaches

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

#VisualAbstract: Definitive chemoradiotherapy and surgical treatment are equally effective primary interventions for patients with advanced oroparyngeal squamous cell carcinoma

#VisualAbstract: Intensity-modulated radiotherapy alone is noninferior to concurrent chemoradiotherapy for low-risk nasopharyngeal carcinoma

#VisualAbstract: Pembrolizumab provides survival benefit in PD-L1 positive advanced head and neck cancer

#VisualAbstract: Chemoradiotherapy with carboplatin is more effective than cetuximab in head and neck squamous cell carcinoma

Wellness Check: Nutrition

#VisualAbstract Changes in minimal residual disease status is associated with risk of disease progression in patients with multiple myeloma

RelatedReports

#VisualAbstract: Intensity-modulated radiotherapy alone is noninferior to concurrent chemoradiotherapy for low-risk nasopharyngeal carcinoma

#VisualAbstract: Pembrolizumab provides survival benefit in PD-L1 positive advanced head and neck cancer

#VisualAbstract: Chemoradiotherapy with carboplatin is more effective than cetuximab in head and neck squamous cell carcinoma

#VisualAbstract: Tislelizumab significantly improves survival outcomes in advanced or metastatic esophageal squamous cell carcinoma

#VisualAbstract Changes in minimal residual disease status is associated with risk of disease progression in patients with multiple myeloma

Chemotherapy during the first trimester of pregnancy associated with increased risk for congenital malformations in fetus

Direct to angiography in transferred patients with large vessel occlusion stroke associated with faster treatment and better outcomes vs repeat imaging approaches

License Our Award-Winning Physician-Written Medical News and Visual Abstracts

2MM+ Premium Access

Recent Reports

Want more physician-written
medical news?

#VisualAbstract: Definitive chemoradiotherapy and surgical treatment are equally effective primary interventions for patients with advanced oroparyngeal squamous cell carcinoma

RELATED REPORTS

Wellness Check: Nutrition

#VisualAbstract Changes in minimal residual disease status is associated with risk of disease progression in patients with multiple myeloma

RelatedReports

License Our Award-Winning Physician-Written Medical News and Visual Abstracts

2MM+ Premium Access

Recent Reports

Want more physician-written medical news?

Want more physician-written
medical news?